Browse Studies — Arctuva

Phase 1

Pilot Study of Pre-emptive Anakinra for the Prevention of Severe Cytokine Release Syndrome in Children and Young Adults With B-Acute Lymphoblastic Leukemia Receiving Chimeric Antigen Receptor (CAR) T Cells

Objectives: The primary objective of this study will be to evaluate the impact of pre-emptive use of anakinra on the rate of severe cytokine release syndrome (…

B-Acute Lymphoblastic LeukemiaCAR-T Cell TherapyCytokine Release Syndrome+2 more

Estimated

~$10 – $7,500

Kevin McNerneyNCT06703216

Observational

Coping Skills Training for Symptom Management and Daily Steps (Step Up)

The aim of this study is to test the efficacy of a hybrid in-person and mHealth coping skills training and activity coaching intervention (Step Up), to enable …

Hematopoietic Stem Cell TransplantCAR-T Cell Therapy

Estimated

~$10 – $6,250

Duke UniversityNCT06575712

Observational

Nutrition OUtReach In Systems of Healthcare

Many children and adults receiving medical treatments have higher costs, which can make it harder for them to afford groceries. When someone can't afford enoug…

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONAutologous Haemopoietic Stem Cell TransplantCAR-T Cell Therapy+1 more

Estimated

~$10 – $6,250

University of Kansas Medical CenterNCT06802406

Phase 4

Seroconversion Following RSV Vaccination in Bone Marrow Transplant and CAR-T Patients

This study evaluates whether the RSV vaccine Abrysvo can produce an antibody response in patients with blood cancers who have previously received a hematopoiet…

CAR-T Cell TherapyRSV ImmunizationBone Marrow Transplant - Autologous or Allogeneic

Estimated

~$10 – $6,250

The Cooper Health SystemNCT07296120